The company will no longer refinance its existing credit agreement, stopping Bausch Health Americas from issuing $3.25 billion in secured debt securities and rescinding its offers to redeem $3.25 billion in aggregate principal of the company’s senior secured notes due in 2022 and 2024.
In a statement made March 2, the company said it “will continue to monitor market conditions and consider opportunistic refinancing transactions from time to time.”
More articles on surgery centers:
Takeda continues non-core asset sell-off for $825M
Philadelphia researchers develop 3D modeling software for previously unviewable portion of colon
FDA awards esophageal DNA test breakthrough device designation
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
